A smart multifunctional drug delivery nanoplatform for targeting cancer cells.
暂无分享,去创建一个
B. Nelson | S. Pané | Xiangzhong Chen | M. Hoop | Fajer Mushtaq | F. Mushtaq | C. Hurter | X.-Z. Chen | B. J. Nelson | M. Hoop | F. Mushtaq | C. Hurter | X.-Z. Chen | S. Pané | Bradley J. Nelson
[1] Chandra P. Sharma,et al. Chitosan and Its Derivatives for Drug Delivery Perspective , 2011 .
[2] Natalia L. Komarova,et al. Cancer: Calculated treatment , 2013, Nature.
[3] V. Pokharkar,et al. Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: A technical note , 2006, AAPS PharmSciTech.
[4] R. Mahato,et al. Pharmaceutical perspectives of cancer therapeutics , 2009 .
[5] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[6] Vincent M Rotello,et al. Functionalized gold nanoparticles for drug delivery. , 2007, Nanomedicine.
[7] M. Bermejo,et al. Hydrogels: an interesting strategy for smart drug delivery. , 2013, Therapeutic delivery.
[8] Krishnendu Chatterjee,et al. Evolutionary dynamics of cancer in response to targeted combination therapy , 2013, eLife.
[9] Vladimir P Torchilin,et al. Passive and active drug targeting: drug delivery to tumors as an example. , 2010, Handbook of experimental pharmacology.
[10] Tejraj M Aminabhavi,et al. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[11] Patrick Couvreur,et al. Stimuli-responsive nanocarriers for drug delivery. , 2013, Nature materials.
[12] David J. Cappelleri,et al. Controlling multiple microrobots: recent progress and future challenges , 2015 .
[13] G. Schwartsmann,et al. Natural products in anticancer therapy. , 2001, Current opinion in pharmacology.
[14] T. Allen. Ligand-targeted therapeutics in anticancer therapy , 2002, Nature Reviews Cancer.
[15] S. Rodenhuis,et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. , 1998, Journal of the National Cancer Institute.
[16] A. Salahudeen,et al. Hypertension in cancer patients. , 2011, Texas Heart Institute journal.
[17] K. B. Sutradhar,et al. Nanotechnology in Cancer Drug Delivery and Selective Targeting , 2014 .
[18] I. Tannock,et al. Acid pH in tumors and its potential for therapeutic exploitation. , 1989, Cancer research.
[19] Ioannis K. Kaliakatsos,et al. Microrobots for minimally invasive medicine. , 2010, Annual review of biomedical engineering.
[20] Salvador Pané,et al. Magnetoelectric micromachines with wirelessly controlled navigation and functionality , 2016 .
[21] M. Ferrari. Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.
[22] G. Wondrak. NQO1-activated phenothiazinium redox cyclers for the targeted bioreductive induction of cancer cell apoptosis. , 2007, Free radical biology & medicine.
[23] Shishir Shishodia,et al. Molecular targets of dietary agents for prevention and therapy of cancer. , 2006, Biochemical pharmacology.
[24] R. Tiwari,et al. Drug delivery systems: An updated review , 2012, International journal of pharmaceutical investigation.
[25] S. Ganta,et al. A review of stimuli-responsive nanocarriers for drug and gene delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[26] P Grigsby,et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] Dong Choon Hyun,et al. Engineered nanoparticles for drug delivery in cancer therapy. , 2014, Angewandte Chemie.
[28] P. Gupta,et al. Hydrogels: from controlled release to pH-responsive drug delivery. , 2002, Drug discovery today.
[29] K. Leong,et al. Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles. , 2015, Nanoscale.
[30] Martin Pumera,et al. Fabrication of Micro/Nanoscale Motors. , 2015, Chemical reviews.
[31] Chih-Kuang Chen,et al. Synthesis of pH-responsive chitosan nanocapsules for the controlled delivery of doxorubicin. , 2014, Langmuir : the ACS journal of surfaces and colloids.
[32] C. Hierold,et al. Degradable Magnetic Composites for Minimally Invasive Interventions: Device Fabrication, Targeted Drug Delivery, and Cytotoxicity Tests , 2016, Advanced materials.
[33] Arti Vashist,et al. Recent advances in hydrogel based drug delivery systems for the human body. , 2014, Journal of materials chemistry. B.
[34] S. Fusco,et al. Chitosan Electrodeposition for Microrobotic Drug Delivery , 2013, Advanced healthcare materials.
[35] R. Jayakumar,et al. Chitosan for Biomaterials II , 2011 .
[36] S. Cheng,et al. Surface functionalized gold nanoparticles for drug delivery. , 2013, Journal of biomedical nanotechnology.
[37] Adriele Prina-Mello,et al. High content analysis of the biocompatibility of nickel nanowires , 2009 .
[38] Salvador Pané,et al. Magnetically Driven Silver‐Coated Nanocoils for Efficient Bacterial Contact Killing , 2016 .
[39] A. Hopkins,et al. The role of ligand efficiency metrics in drug discovery , 2014, Nature Reviews Drug Discovery.
[40] Vincent M Rotello,et al. Gold nanoparticles in delivery applications. , 2008, Advanced drug delivery reviews.
[41] Mark D Pagel,et al. Evaluating pH in the Extracellular Tumor Microenvironment Using CEST MRI and Other Imaging Methods. , 2015, Advances in radiology.
[42] J. Karp,et al. Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .
[43] R. Hurt,et al. Bioavailability, intracellular mobilization of nickel, and HIF-1α activation in human lung epithelial cells exposed to metallic nickel and nickel oxide nanoparticles. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[44] Jens Lienig,et al. Review on Hydrogel-based pH Sensors and Microsensors , 2008, Sensors.
[45] R. Reid,et al. Hydrogel drug delivery system with predictable and tunable drug release and degradation rates , 2013, Proceedings of the National Academy of Sciences.
[46] S. De Flora,et al. Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention , 2010, Journal of the National Cancer Institute.
[47] M. Serra,et al. Nickel, cobalt and chromium-induced cytotoxicity and intracellular accumulation in human hacat keratinocytes. , 2001, Toxicology.
[48] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[49] G. Lu,et al. A pH-responsive drug delivery system based on chitosan coated mesoporous silica nanoparticles , 2012 .
[50] R. Thangam,et al. pH-responsive drug delivery of chitosan nanoparticles as Tamoxifen carriers for effective anti-tumor activity in breast cancer cells. , 2013, Colloids and surfaces. B, Biointerfaces.